UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

The gut microbiota and host health: a new clinical frontier

Gut, 2016-02, Vol.65 (2), p.330-339

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Pulmonary Neutrophilic Inflammation in Emphysema by Quantitative Positron Emission Tomography

American journal of respiratory and critical care medicine, 2012-12, Vol.186 (11), p.1125-1132

2012

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of pouchitis in both ulcerative colitis and familial adenomatous polyposis: A systematic review and meta‐analysis

Colorectal disease, 2022-01, Vol.24 (1), p.27-39

2022

Link zum Volltext

Verfügbarkeit prüfen

Multi-modality detection of SARS-CoV-2 in faecal donor samples for transplantation and in asymptomatic emergency surgical admissions [version 1; peer review: 2 approved]

F1000 research, 2021, Vol.10, p.373-373

2021

Link zum Volltext

Verfügbarkeit prüfen

Meta‐analysis of the demographic and prognostic significance of gastrointestinal symptoms in COVID‐19 patients

JGH open, 2022-10, Vol.6 (10), p.711-722

2022

Link zum Volltext

Verfügbarkeit prüfen

Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis

EBioMedicine, 2022-07, Vol.81, p.104088-104088, Article 104088

2022

Link zum Volltext

Verfügbarkeit prüfen

The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease

Therapeutic Advances in Gastroenterology, 2019-01, Vol.12, p.1756284818822250-1756284818822250

2019

Link zum Volltext

Verfügbarkeit prüfen

The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam

Frontiers in microbiology, 2023-03, Vol.14, p.1134105-1134105

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-Analysis

Journal of Crohn's and colitis, 2021-07, Vol.15 (7), p.1184-1196

2021

Link zum Volltext

Verfügbarkeit prüfen

Integration of stool microbiota, proteome and amino acid profiles to discriminate patients with adenomas and colorectal cancer

Gut microbes, 2022-12, Vol.14 (1), p.2139979-2139979

2022

Link zum Volltext

Verfügbarkeit prüfen

Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease

Therapeutic Advances in Gastroenterology, 2019, Vol.12, p.1756284819891038-1756284819891038

2019

Link zum Volltext

Verfügbarkeit prüfen

Predicting the current and future prevalence of primary sclerosing cholangitis with inflammatory bowel disease (PSC-IBD): a nationwide population-based study

Journal of hepatology, 2023-06, Vol.78, p.S368-S369

2023

Link zum Volltext

Verfügbarkeit prüfen

WED-251 - Predicting the current and future prevalence of primary sclerosing cholangitis with inflammatory bowel disease (PSC-IBD): a nationwide population-based study

Journal of hepatology, 2023-06, Vol.78, p.S368-S369

2023

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement

The lancet. Gastroenterology & hepatology, 2021-03, Vol.6 (3), p.218-224

2021

Link zum Volltext

Verfügbarkeit prüfen

Advances in Biliary Tract Disorders: Novel Biomarkers, Pharmacotherapies, Endoscopic Techniques, and Surgical Management

Gastroenterology research and practice, 2016-01, Vol.2016, p.1583486-2

2016

Link zum Volltext

Verfügbarkeit prüfen

Oral vancomycin induces remission in PSC-IBD, which is associated with a reduction in bile salt hydrolase and colonic amine oxidase activity

Journal of hepatology, 2023-06, Vol.78, p.S123-S124

2023

Link zum Volltext

Verfügbarkeit prüfen

LBP-36 - Oral vancomycin induces remission in PSC-IBD, which is associated with a reduction in bile salt hydrolase and colonic amine oxidase activity

Journal of hepatology, 2023-06, Vol.78, p.S123-S124

2023

Link zum Volltext

Verfügbarkeit prüfen

P694 Age is a strong of predictive risk factor for anti-TNF therapy related adverse events in IBD patients

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1314-i1315

2024

Link zum Volltext

Verfügbarkeit prüfen

Emerging drugs for the treatment of primary sclerosing cholangitis

Current opinion in pharmacology, 2022-02, Vol.62, p.23-35

2022

Link zum Volltext

Verfügbarkeit prüfen

P756 Cumulative adverse events of anti-TNF therapy in IBD patients at a large tertiary centre – a 13-year real-world experience

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i888-i888

2023

Link zum Volltext

Verfügbarkeit prüfen

Gut microbiome and autoimmune disorders

Clinical and experimental immunology, 2022-08, Vol.209 (2), p.161-174

2022

Link zum Volltext

Verfügbarkeit prüfen

A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease

Inflammatory bowel diseases, 2013-04, Vol.19 (5), p.999-1003

2013

Link zum Volltext

Verfügbarkeit prüfen

MYOD-1 in normal colonic mucosa--role as a putative biomarker?

BMC research notes, 2012-07, Vol.5 (1), p.240-240, Article 240

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(72)
Dissertationen
(1)

Sprache

Englisch
(73)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The gut microbiota and host health: a new clinical frontier

Assessment of Pulmonary Neutrophilic Inflammation in Emphysema by Quantitative Positron Emission Tomography

Prevalence of pouchitis in both ulcerative colitis and familial adenomatous polyposis: A systematic review and meta‐analysis

Multi-modality detection of SARS-CoV-2 in faecal donor samples for transplantation and in asymptomatic emergency surgical admissions [version 1; peer review: 2 approved]

The Paddington International Virtual Chromoendoscopy Score in ulcerative colitis exhibits very good inter-rater agreement after computerized module training: a multicenter study across academic and community practice (with video)

Meta‐analysis of the demographic and prognostic significance of gastrointestinal symptoms in COVID‐19 patients

Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis

The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease

The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam

Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-Analysis

Integration of stool microbiota, proteome and amino acid profiles to discriminate patients with adenomas and colorectal cancer

Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease

Predicting the current and future prevalence of primary sclerosing cholangitis with inflammatory bowel disease (PSC-IBD): a nationwide population-based study

WED-251 - Predicting the current and future prevalence of primary sclerosing cholangitis with inflammatory bowel disease (PSC-IBD): a nationwide population-based study

STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement

Advances in Biliary Tract Disorders: Novel Biomarkers, Pharmacotherapies, Endoscopic Techniques, and Surgical Management

Oral vancomycin induces remission in PSC-IBD, which is associated with a reduction in bile salt hydrolase and colonic amine oxidase activity

LBP-36 - Oral vancomycin induces remission in PSC-IBD, which is associated with a reduction in bile salt hydrolase and colonic amine oxidase activity

P694 Age is a strong of predictive risk factor for anti-TNF therapy related adverse events in IBD patients

Emerging drugs for the treatment of primary sclerosing cholangitis

P756 Cumulative adverse events of anti-TNF therapy in IBD patients at a large tertiary centre – a 13-year real-world experience

Gut microbiome and autoimmune disorders

A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease

MYOD-1 in normal colonic mucosa--role as a putative biomarker?

Suchergebnisse filtern